LGALS9 and acute myeloid leukemia: In line with this finding, ‘short-term’ treatment of a panel of AML lines with Gal-9 (300 nM) strongly and significantly reduced the number of viable cells, as visualized using microscopy for THP-1 (Fig. 1A).